Advancements in the Treatment of Sebaceous Carcinoma: Surgical and Adjuvant Strategies

Sebaceous carcinoma is a rare but aggressive form of skin cancer originating from sebaceous glands. It often presents as a nodular lesion and is most commonly found on the eyelid, although it can occur in other areas of the body. Due to its potential for local recurrence and metastasis, timely and effective treatment is essential. This article explores the latest advancements in surgical and adjuvant treatment options for sebaceous carcinoma. Surgical Management Traditionally, surgical excision has been the cornerstone of treatment for sebaceous carcinoma. The goal of surgery is to achieve clear margins while preserving surrounding healthy tissue. Mohs micrographic surgery (MMS) has gained prominence as a preferred technique for managing high-risk lesions, particularly those located on the eyelid. Mohs Micrographic Surgery MMS provides the advantage of real-time margin assessment, reducing the likelihood of recurrence. Recent studies have demonstrated that MMS not only improves local control rates but also minimizes functional and cosmetic morbidity. The technique is particularly beneficial for tumors on the face and scalp, where aesthetic considerations are paramount. Extent of Surgery The extent of surgical intervention may vary based on tumor size, location, and histological features. In some cases, wide local excision may be sufficient, while others may require more extensive surgical measures, including orbital exenteration for tumors invading surrounding structures. Determining the appropriate surgical approach often involves a multidisciplinary team, including dermatologists, oncologists, and plastic surgeons. Adjuvant Treatment Options While surgery remains the primary treatment modality, adjuvant therapies are increasingly being explored, especially for high-risk patients or those with advanced disease. These options include radiotherapy, chemotherapy, and targeted therapy. Radiotherapy Radiation therapy is often reserved for patients who are not surgical c